Abstract

Remodeling of the extracellular matrix has been implicated in ovarian cancer. To quantitate the remodeling, we implement a form of texture analysis to delineate the collagen fibrillar morphology observed in second harmonic generation microscopy images of human normal and high grade malignant ovarian tissues. In the learning stage, a dictionary of “textons”—frequently occurring texture features that are identified by measuring the image response to a filter bank of various shapes, sizes, and orientations—is created. By calculating a representative model based on the texton distribution for each tissue type using a training set of respective second harmonic generation images, we then perform classification between images of normal and high grade malignant ovarian tissues. By optimizing the number of textons and nearest neighbors, we achieved classification accuracy up to 97% based on the area under receiver operating characteristic curves (true positives versus false positives). The local analysis algorithm is a more general method to probe rapidly changing fibrillar morphologies than global analyses such as FFT. It is also more versatile than other texture approaches as the filter bank can be highly tailored to specific applications (e.g., different disease states) by creating customized libraries based on common image features.

Highlights

  • According to the American Cancer Society, in 2013 about 22,000 new cases of ovarian cancer were diagnosed and about 15,000 women died because of this disease.[1]

  • We use the receiver operating characteristic (ROC) curve formalism[35,36] of true positives versus false positives to determine the accuracy of the classification, where the accuracy is defined as the area under the ROC curve (AUROC)

  • The discrimination threshold is crucial for ROC curve generation, and this was chosen by summing up the weighting of the 10 nearest neighbor (NN) around the testing images

Read more

Summary

Introduction

According to the American Cancer Society, in 2013 about 22,000 new cases of ovarian cancer were diagnosed and about 15,000 women died because of this disease.[1]. CA125 is currently the best serum biomarker, the sensitivity/specificity are both low.[4] For example, about 20% of women with ovarian cancer do not have elevated CA125.2 The achievable resolution of clinical modalities (computed tomography, positron emission tomography, ultrasound, magnetic resonance imaging) is limited (only ∼0.5 to 3 mm) and is not sufficient for imaging microscopic disease. This is especially important for ovarian cancer as metastasis can occur during early stages of tumor growth.[3]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.